May. 17 at 2:13 AM
$VXIT get out! Investing in VXIT poses significant risks due to its precarious financial standing and market performance. The company has reported no revenue and a net loss of
$2 million over the trailing twelve months, with its last financial report dating back to 2019, indicating a lack of transparency and up-to-date financial disclosures . The stock has experienced extreme volatility, with a 35% average weekly movement, and has declined by over 33% in the past year, underperforming both the medical equipment industry and the broader U.S. market . Additionally, a surge in short interest by over 2,200% suggests that investors are increasingly betting against the stock . These factors, combined with a history of shareholder dilution and a market capitalization of just
$2.2 million, make VXIT a highly speculative and potentially unfavorable investment.
